Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It leasr the perosses was started
Sphinx
I doubt they're waiting for any news on Blue Hat. If By-Health get that approved then it would very much justify an RNS of it's own.
It's possible ( though I'd say unlikely, because I'd have thought there'd have been an RNS this week saying a delay was expected ) that the results might not come out next week anyway. Companies can still delay results by up to a month because of COVID
BB
The collaboration agreement between DSM and By-Health was announced in November 2016
https://www.lse.co.uk/rns/PXS/new-collaboration-for-fruitflow-487281ejdgq1q3n.html
2 different agreements
That's not strictly true. The collaboration agreement between provexis and By-health was announced on 2nd after August 2019
https://www.lse.co.uk/rns/PXS/collaboration-agreement-with-by-health-co-ltd-c582ph8xi3mosf7.html
That's what we said last year ,its been five years ,since byhealth and provexis announced joint adventure.
Let's all just hope the hat is blue next year.
I should think Moon is anything than blue! The great escape IMO.
A blue moon then .
When they move from loss to profit.
Is this share ever going to get above 1p
The only reason to leave finals to the last day is that they are giving every chance for the Blue hat to be announced imo , so I am not expecting anything spectacular maybe 10 or 20% more than last year + anything from BY health for research . Maybe something is in the pipeline , i only hope the year after year cycle of refinancing has come to an end .
Di you have a link?
On CNBC
As I recall, this always seems to happen before results for some reason. It drops, the opposite of what you hope.
I totally agree ,with you ,these Mms are playing games ,with loyal share ,who have been through thick and thin .
The problem is that ,we are not getting any updates ,which hasn't happened for eight months
i think its not just the MMs who are taking the michael.
I think everyone here knows a bit too much to fall for soppy tactics like this.
Well funded, development progress made, but sales and bottom line still a big "known unknown" IMHO
The MMS are taking the p... with the spread today. They have no idea what the results will be
19/20 total £348k
——- H1 19/20- £222k
——-H2 19/20 - £126k (Q4 Covid impacted)
20/21
H1 20/21 - £237k
H2 TBC, but Q3 half well above previous year.
I think last years (19/20) results were impacted by Covid in Q4 (Jan/Feb/Mar when Covid hit EU) resulting in much lower revenue being reported.
This year we may see
20/21 H1 - £237k
20/21 H2 - £245k (guesstimate)
Total - £482k compared to £348k the previous year.
This could bring the operating loss down to about £100k.
Plus any contributions from By-Health to PXS
You would think it has been completed ! As you say the £8k was paid last year and we were expected to get the £55k+ last year , even taking covid into account that’s a long time to complete one research project .
Sphinx, the interim results showed income of £8,346 for Fruitflow+ nitrates - in development.
Doesn't indicate this is from by-health but assume it is. You are correct though we are still due the remaining cash if we have completed the work.
Gixer shouldn’t we get the ff+nitrates money from By-health (£47k) in these coming results , I also wonder if any other research projects have been commissioned from byhealth , but who knows with pxs and results .
Kievsky
You have know idea what the price maybe so why speculate
We all just have to be patient. Will explode once approved and announced. Then DSM and bi-Heath will have to fight for us. As I said I want 5p plus. 10p would be a great result. But on spike it could go to 12p plus at some time. Of course if blue hat gets refused then we will hope bi-health release there products without it.
Hi gixer,
Many thanks for your very informative post. Hope By Health will be our saviour and want to buy us outright with the right price tag. Then suddenly DSM wakes up and made a counter offer. Probably SL will have the key decision to go which direction we should go.